Genes predict if medication can help you quit smoking
A new study shows the same gene variations that make it difficult to stop smoking also increase the likelihood that heavy smokers will respond to nicotine-replacement therapy and drugs that thwart cravings. The finding suggests it may one day be possible to predict which patients are most likely to benefit from drug treatments for nicotine addiction.
Dacey becomes president of neurosurgery society
Ralph G. Dacey Jr., MD, the Henry G. and Edith R.
Schwartz Professor and head of the Department of Neurosurgery at
Washington University School of Medicine in St. Louis, became president
of the Society of Neurological Surgeons (SNS) May 22, 2012.
World’s largest hunk of cancer genome data released
St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project has announced the largest release to date of comprehensive human cancer genome data for free access by the global scientific community.
Tychsen named Hardesty distinguished professor
Pediatric ophthalmologist R. Lawrence Tychsen, MD, has been named the John F. Hardesty, MD, Distinguished Professor of Ophthalmology and Visual Sciences at Washington University School of Medicine in St. Louis.
IUDs, implants are most effective birth control
A study by Brooke Winner, MD (pictured), and Jeff Peipert, MD, to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than those who used longer-acting forms such as an intrauterine device (IUD) or implant.
Commencement 2012: New beginnings
Larry J. Shapiro, MD, executive vice chancellor for
medical affairs and dean of the School of Medicine, congratulates
Kristen E. Ziara Harring, as he hands her her Doctor of Medicine degree
at the School of Medicine Commencement Recognition Ceremony May 18 at
the America’s Center. At the ceremony, 127 students received degrees.
Washington University receives $3 million to design cancer-killing viruses
Researchers at Washington University School of Medicine in St. Louis have received a $3 million grant from the National Cancer Institute (NCI) to develop a triple threat in the fight against cancer: a single virus equipped to find, image and kill cancer cells, all at once.
Folic acid may reduce some childhood cancers
Folic acid fortification of foods may reduce the incidence of the most common type of kidney cancer and a type of brain tumors in children, finds a new study by Kimberly J. Johnson, PhD, assistant professor at the Brown School at Washington University in St. Louis, and Amy Linabery, PhD, postdoctoral fellow at the University of Minnesota. Incidence reductions were found for Wilms’ tumor, a type of kidney cancer, and primitive neuroectodermal tumors (PNET), a type of brain cancer.
Recommendation against PSA test too drastic
A new recommendation issued today by the U.S. Preventive Services Task Force against routine PSA testing for healthy men age 50 and older goes too far, says a prostate cancer expert at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.
Less invasive alternative to colonoscopy reduces colon cancer deaths
A less invasive screening test for colorectal cancer reduces deaths from the disease but is probably not as effective as colonoscopy, the gold standard.
Older Stories